ZHAO Xiaoya, TANG Xiaowei, XIAO Wenhuan, DONG Wei. Effect of repetitive transcranial magnetic stimulation combined with amisulpride in treatment of schizophrenia and its influence on cognitive function[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 89-91, 96. DOI: 10.7619/jcmp.20222325
Citation: ZHAO Xiaoya, TANG Xiaowei, XIAO Wenhuan, DONG Wei. Effect of repetitive transcranial magnetic stimulation combined with amisulpride in treatment of schizophrenia and its influence on cognitive function[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 89-91, 96. DOI: 10.7619/jcmp.20222325

Effect of repetitive transcranial magnetic stimulation combined with amisulpride in treatment of schizophrenia and its influence on cognitive function

More Information
  • Received Date: July 28, 2022
  • Available Online: December 22, 2022
  • Objective 

    To observe the effect of repetitive transcranial magnetic stimulation (rTMS) combined with amisulpride in the treatment of schizophrenia and its influence on cognitive function.

    Methods 

    A total of 100 schizophrenia patients were enrolled as study objects, and they were randomly divided into study group and control group, with 50 patients in each group. The control group was treated with amsulpiride, and the study group was treated with amsulpiride combined with rTMS. The clinical symptom score, therapeutic effect and cognitive function score of the two groups were compared.

    Results 

    Before treatment, there was no significant difference in clinical symptom score between the two groups (P>0.05). After treatment, the general psychopathological score, positive symptom score, and negative symptom score of the study group were(30.13±1.23), (12.31±2.01), (17.91±4.15), which were lower than (33.17±2.15), (14.31±1.33), (20.31±3.17), respectively in the control group (P < 0.05). The total effective rate of the study group was 96.00% (48/50), which was higher than 68.00% (34/50) of the control group, and the difference was statistically significant (P < 0.05). Before treatment, there was no significant difference in cognitive function score between the two groups (P>0.05). After treatment, the item scores of all dimensions of cognitive function and total score in the study group were higher than those in the control group, and the differences were statistically significant (P < 0.05 or P < 0.01).

    Conclusion 

    In the treatment of schizophrenia patients, rTMS combined with amisulpride can improve cognitive function and therapeutic effect, and relieve mental symptoms compared with amisulpride treatment alone.

  • [1]
    钟远惠, 何晓华, 林壮国, 等. 氨磺必利联合奥氮平治疗慢性精神分裂症的疗效观察[J]. 广东药科大学学报, 2020, 36(2): 271-273. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYX202002022.htm
    [2]
    张玥, 唐小伟, 肖文焕, 等. 血清表皮生长因子和C反应蛋白与精神分裂症患者认知功能的关系[J]. 实用临床医药杂志, 2022, 26(11): 76-80, 86. doi: 10.7619/jcmp.20215055
    [3]
    KAHN R S, KEEFE R S. Schizophrenia is a cognitive illness: time for a change in focus[J]. JAMA Psychiatry, 2013, 70(10): 1107-1112. doi: 10.1001/jamapsychiatry.2013.155
    [4]
    唐小伟, 耿德勤, 沙维伟, 等. 缺陷型精神分裂症患者认知功能的研究[J]. 实用临床医药杂志, 2013, 17(11): 59-61. doi: 10.7619/jcmp.201311019
    [5]
    巫彩莲, 吴晓雄, 郁缪宇. 重复经颅磁刺激治疗精神疾病临床研究进展[J]. 临床精神医学杂志, 2022, 32(3): 243-245. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJS202203020.htm
    [6]
    张保华, 谭云龙, 张五芳, 等. 重复性成套神经心理状态测验的信度、效度分析[J]. 中国心理卫生杂志, 2008, 22(12): 865-869. doi: 10.3321/j.issn:1000-6729.2008.12.001
    [7]
    GRYNSZPAN O, PERBAL S, PELISSOLO A, et al. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study[J]. Psychol Med, 2011, 41(1): 163-173. doi: 10.1017/S0033291710000607
    [8]
    宫雪. 氨磺必利与氯氮平治疗阴性症状为主精神分裂症患者临床疗效的对比观察[J]. 医学理论与实践, 2020, 33(4): 571-573. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLL202004023.htm
    [9]
    郗玲燕, 金圭星, 张素允, 等. 齐拉西酮联合氯丙嗪治疗老年精神分裂症患者的疗效分析[J]. 实用临床医药杂志, 2021, 25(16): 116-119. doi: 10.7619/jcmp.20211029
    [10]
    张志勇, 原富强, 程德君. 奥氮平联合氨磺必利治疗精神分裂症的效果及其对睡眠和认知功能的影响[J]. 国际精神病学杂志, 2020, 47(1): 43-45, 57. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ202001013.htm
    [11]
    吴涛, 彭智勇, 刘龙平. 氨磺必利联合奥氮平治疗精神分裂症患者的临床效果[J]. 医疗装备, 2020, 33(3): 87-88. https://www.cnki.com.cn/Article/CJFDTOTAL-YLZB202003048.htm
    [12]
    金学敏. 温胆汤联合氨磺必利治疗难治性精神分裂症患者的疗效[J]. 医疗装备, 2019, 32(24): 132-133. https://www.cnki.com.cn/Article/CJFDTOTAL-YLZB201924089.htm
    [13]
    俞萍, 肖文焕, 赵义林, 等. 氨磺必利对青少年精神分裂症患者社会功能和神经认知的影响[J]. 实用临床医药杂志, 2021, 25(22): 67-70. doi: 10.7619/jcmp.20211561
    [14]
    孙来顺. 精神分裂症的药物治疗[J]. 医学信息, 2021, 34(21): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXX202121010.htm
    [15]
    ZHUO K, WANG Y, SONG Z, et al. Effects of rTMS on cognitive and negitive symptoms of schizophrenia: A randomized double-blind sham-controlled study[J]. Eur Psychiatry, 2016, 33: S335-S335.
    [16]
    穆小梅, 王秀梅, 牛慧明, 等. 奥氮平与氨磺必利联合用药方案治疗难治性精神分裂症的临床价值评价[J]. 中国全科医学, 2019, 22(S2): 258-259. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2019S2091.htm
    [17]
    陈敏梅, 黎海雁, 蔡守彬, 等. 氨磺必利联合氯氮平治疗慢性精神分裂症的疗效及对血清泌乳素、认知功能的影响[J]. 中国处方药, 2019, 17(12): 84-85. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF201912050.htm
    [18]
    QUINTERO J, BARBUDO E, MOLINA J D, et al. The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study[J]. J Clin Psychopharmacol, 2011, 31(2): 240-242.
    [19]
    朱玉华, 朱丽萍, 吴海苏. 精神分裂症认知功能障碍的病因研究进展[J]. 精神医学杂志, 2010, 23(4): 303-305. https://www.cnki.com.cn/Article/CJFDTOTAL-SDJB201004032.htm
  • Related Articles

    [1]MEI Hanwei, QIU Minghan, SONG Teng, WU Shan, ZHAO Ke, ZOU Dandan, LI Shuping, HE Guopping, ZHAO Xuanzhu, WANG Huaqing. Correlations between TCM syndromes and clinical factors after colorectal cancer surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 62-66. DOI: 10.7619/jcmp.20223015
    [2]JI Hongjuan, QIAO Dawei, TAO Yuhua. Influencing factors of anxiety and depression in lung cancer patients and analysis in Chinese traditional medicine syndromes[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 60-63, 69. DOI: 10.7619/jcmp.20220656
    [3]FENG Zhenfeng, YAN Jun, SHI Jinjuan, LIU Manman, HU Chunping. Effects of Bushen Huoxue Decoction for patients with non-obese polycystic ovary syndrome and its effects on score of traditional Chinese medicine syndrome and ovarian function[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 90-93. DOI: 10.7619/jcmp.202020025
    [4]GU Wenyan, WANG Li, MA Caiyu, DING Chunlei, QIAN Fenghua, ZHAO Lei. Effect of retention enema by Shengjiang Powder in treating ventilator-associated pneumonia differentiated as phlegm-heat congesting in lungs syndrome on TCM syndrome scores, curative effect and related inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 69-72. DOI: 10.7619/jcmp.202001018
    [5]MAO Xue, ZHAO Xin. Effect of Qingfei Tongfu Decoction on the lung function, score of TCM syndrome and levels of inflammatory factors in patients with severe pneumonia differentiated as syndrome of obstruction of phlegm-heat in lung[J]. Journal of Clinical Medicine in Practice, 2019, 23(16): 51-53, 57. DOI: 10.7619/jcmp.201916014
    [6]LIU Chenxia, GENG Feng. Effect of Wendan Decoction on score of TCM syndromes in patients with gastric distention and fullness[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 17-20. DOI: 10.7619/jcmp.201914004
    [7]YU Jiafeng, ZHU Hui, GUO Yaoyao, LI Xia, LIU Kefu, XIE Ping. Values of transcranial Doppler ultrasound classificationand TCM syndromes in the treatment of patients with vertebrobasilar insufficiency vertigo[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 11-13. DOI: 10.7619/jcmp.201911003
    [8]CHEN Shujian. Effect of activating blood and eliminating phlegm on TCM syndrome scores and lung function in outpatients with bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2019, (1): 52-55. DOI: 10.7619/jcmp.201901014
    [9]GUO Feng, ZHANG Shuli, YIN Xiaoying. Effect of routine treatment of western medicine combined with nasal feeding of qingqi liangying decoction on inflammatory reaction, pulmonary function and TCM syndrome score in emergency patients with ventilator-associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2018, (7): 45-47,52. DOI: 10.7619/jcmp.201807012
    [10]LU Yonghua, ZHANG Hongli, LI Jiao, GU Hao. Effect of nursing intervention on gastrointestinal reaction and negative emotion of cancer patients during chemotherapy[J]. Journal of Clinical Medicine in Practice, 2017, (12): 84-87. DOI: 10.7619/jcmp.201712025
  • Cited by

    Periodical cited type(3)

    1. 张尤佳,王焕勇,高明杰,刘宇毅,姜霄鹰,朱芙丽,彭如臣. 颈动脉超声联合心脏超声对冠心病患者不良预后的评估价值. 中国循证心血管医学杂志. 2024(05): 607-610 .
    2. 魏星,陈芊颖,龚厚文,许锋成,韩立明,葛斌,龚大彩. 基于GEO数据库生物信息学筛选动脉粥样硬化铁死亡关键基因和实验验证. 现代检验医学杂志. 2024(05): 112-119 .
    3. 陈永成. 吲哚布芬联合氯吡格雷治疗对冠心病PCI术后患者心肌灌注、NT-proBNP及MACE的影响. 临床研究. 2023(10): 53-56 .

    Other cited types(1)

Catalog

    Article views (172) PDF downloads (10) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return